How is the Lyra Therapeutics Inc today?

The Lyra Therapeutics Inc today is trading in the down by -1.60% at 4.93.

What is Lyra Therapeutics Inc Annual Revenue?

Lyra Therapeutics Inc Annual Revenue fell 1.54%, in the last year to $1.53 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Lyra Therapeutics Inc Annual Net Profit?

Lyra Therapeutics Inc Annual Net Profit fell 49.07% in the last year to $93.44 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Lyra Therapeutics Inc Price to Earning Ratio?

Lyra Therapeutics Inc Price to Earning Ratio is -0.08, which is negative.

What is Lyra Therapeutics Inc Stock Price?

Lyra Therapeutics Inc Stock Price fell 69.94% and underperformed its sector by 125.41% in the past year.

What is Lyra Therapeutics Inc Quarterly Revenue?

Lyra Therapeutics Inc Quarterly Revenue fell 65.6% YoY to $0.18 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Lyra Therapeutics Inc Quarterly Net profit?

Lyra Therapeutics Inc Quarterly Net profit rose 61.93% YoY to $8.55 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Lyra Therapeutics Inc Debt to Equity Ratio?

Lyra Therapeutics Inc Debt to Equity Ratio of 2.97 is higher than 1. This implies that company assets are financed through debt.

What is Lyra Therapeutics Inc Return on Equity(ROE)?

Lyra Therapeutics Inc Return on Equity(ROE) for the last financial year was -184.99%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Lyra Therapeutics Inc Mutual Fund Holding?

Lyra Therapeutics Inc Mutual Fund Holding decreased by 10.14% in the last quarter to 0.87.

What is Lyra Therapeutics Inc Institutional Holding?

Lyra Therapeutics Inc Institutional Holding decreased by 33.74% in the last quarter to 0.8.

Lyra Therapeutics Inc XNAS: LYRA

Lyra Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Lyra Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Lyra Therapeutics Inc
Rating: 1.16641675
Author: Trendlyne DVM scores

about

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business...

4.93 -0.08 (-1.60%)

New 52W Low in past week

60,308 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

21.7 / 100

Technically Bearish

25.0 / 100

63

1Yr Price target upside is 1168%

2 analysts

Lyra Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lyra Therapeutics Inc FAQ

How is Lyra Therapeutics Inc today?

Lyra Therapeutics Inc today is trading in the red, and is down by -1.60% at 4.93.

How has Lyra Therapeutics Inc performed historically?

Lyra Therapeutics Inc is currently trading down -1.60% on an intraday basis. In the past week the stock rose 7.17%. stock has been down -53.93% in the past quarter and fell -69.94% in the past year. You can view this in the overview section.